SAB BIOTHERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
SAB BIOTHERAPEUTICS, INC. (SABS) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $382.21 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-03-09
- SAB BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $382.21K.
- SAB BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SAB BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $340.76K, a 58.51% decline from fiscal 2022.
- SAB BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $821.36K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2025-12-31 | $382.21K 10-K · filed 2026-03-09 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-12-31 | $340.76K 10-K · filed 2025-03-31 |
| 2022-12-31 | $821.36K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |